Elite Pharmaceuticals ELTP
OTC ELTP
$0.25 0.00 (-0.08%)
As of: Oct 23, 2026 · 12:45 PM EDT

Elite Pharmaceuticals (ELTP) Return on Equity [ROE] (2016 - 2026)

Updated

Elite Pharmaceuticals' Return on Equity [ROE] was 55.64% in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 77.18 percentage points from -21.54% a year earlier and up 5.55 percentage points from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Return on Equity [ROE] (2016 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Return on Equity [ROE] at Elite Pharmaceuticals came in at 58.89%, up 66.81 percentage points from FY2025.

  • Return on Equity [ROE] shows a five-year change of +27.97 percentage points (FY2021 to FY2026).
  • In earlier fiscal years, Return on Equity [ROE] was -7.92% in FY2025 (-54.48 pp), 46.56% in FY2024 (+33.41 pp), 13.15% in FY2023 (-25.72 pp) and 38.87% in FY2022 (+7.95 pp).
  • Quarterly Return on Equity [ROE] has moved between -42.88% (fiscal Q3 2025) and 61.06% (fiscal Q3 2026) over five years.
  • Compared with a year earlier, Return on Equity [ROE] has increased for four straight quarters, with an average year-over-year change of +4.76 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was fiscal Q3 2026 (a gain of 103.95 percentage points); the worst was fiscal Q3 2025 (a drop of 76.88 percentage points).
  • Per Business Quant data, ELTP's Return on Equity [ROE] in the three fiscal quarters before Q1 2027 was 50.08% (Q4 2026), 61.06% (Q3 2026) and 25.33% (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,134.76 Bn 1,103.34 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 634.69 Bn 554.55 Bn 17.30 Bn 19.33%
3 AbbVie 506.51 Bn 479.62 Bn 12.70 Bn -
4 Merck 357.95 Bn 312.33 Bn 12.21 Bn 7.21%
5 Novartis Ag 293.14 Bn 257.13 Bn 11.24 Bn 31.52%
6 Astrazeneca 265.38 Bn 239.06 Bn 12.86 Bn 21.39%
7 Amgen 238.37 Bn 193.77 Bn 7.24 Bn 83.75%
8 Gilead Sciences 195.16 Bn 169.36 Bn 6.22 Bn -18.38%
9 Pfizer 170.88 Bn 117.53 Bn 10.94 Bn 4.97%
10 Elite Pharmaceuticals 269.09 Mn 150.77 Mn 13.51 Mn 55.64%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 55.64%
Mar 31, 2026 50.08%
Dec 31, 2025 61.06%
Sep 30, 2025 25.33%
Jun 30, 2025 -21.54%
Mar 31, 2025 -9.78%
Dec 31, 2024 -42.88%
Sep 30, 2024 -12.04%
Jun 30, 2024 33.88%
Mar 31, 2024 38.74%
Dec 31, 2023 33.99%
Sep 30, 2023 47.38%
Jun 30, 2023 14.89%
Mar 31, 2023 12.04%
Dec 31, 2022 25.17%
Sep 30, 2022 24.78%
Jun 30, 2022 26.85%
Mar 31, 2022 33.50%
Dec 31, 2021 23.70%
Sep 30, 2021 24.78%
API Access

Elite Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ELTP&period=max&api_key=YOUR_API_KEY